GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurocrine Biosciences Inc (LTS:0K6R) » Definitions » Investments And Advances

Neurocrine Biosciences (LTS:0K6R) Investments And Advances : $771 Mil (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Neurocrine Biosciences Investments And Advances?

Neurocrine Biosciences's Investments And Advances for the quarter that ended in Sep. 2024 was $771 Mil.

Neurocrine Biosciences's quarterly Investments And Advances declined from Mar. 2024 ($864 Mil) to Jun. 2024 ($781 Mil) and declined from Jun. 2024 ($781 Mil) to Sep. 2024 ($771 Mil).

Neurocrine Biosciences's annual Investments And Advances declined from Dec. 2021 ($624 Mil) to Dec. 2022 ($402 Mil) but then increased from Dec. 2022 ($402 Mil) to Dec. 2023 ($849 Mil).


Neurocrine Biosciences Investments And Advances Historical Data

The historical data trend for Neurocrine Biosciences's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurocrine Biosciences Investments And Advances Chart

Neurocrine Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only 355.60 265.30 624.40 401.50 849.40

Neurocrine Biosciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 587.50 849.40 863.90 781.40 770.60

Neurocrine Biosciences Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Neurocrine Biosciences Business Description

Traded in Other Exchanges
Address
12780 El Camino Real, San Diego, CA, USA, 92130
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

Neurocrine Biosciences Headlines

No Headlines